The role of sympathetic glial cells in a variety of parasitic diseases remains unknown, despite the clear relevance of their infection and response to parasites to neuronal lesions in autonomic and enteric ganglia. Many studies have elucidated crucial roles for glial cells in neuropathological situations through the release of trophic factors, neuroprotective molecules or neurotoxic chemicals that mediate neuronal survival, function, lesion or death ([@B22], [@B24]). Glial cells are in close contact with neurons in both the central and peripheral nervous systems and are believed to affect them to a greater degree than inflammatory cells and their products ([@B5], [@B3], [@B20], [@B51]). In intestinal Chagas disease, parasitised glial cells and neuronal cells in close proximity to damaged myenteric ganglia is a frequent finding ([@B45], [@B6]). Thus, it is extremely important to elucidate how glial cells are activated by and respond to pathogens, which will help to clarify the mechanisms of pathogenesis for numerous nervous system diseases.

Central glial cells such as astrocytes and microglia have been investigated in vitro and the intracellular pathways activated in response to various stimuli are well established ([@B31], [@B41]). However, despite their important roles, peripheral glial cells have not been equally well investigated ([@B26], [@B27]).

In this study, we used a superior cervical ganglion (SCG) glial cell culture that was standardised by our group ([@B2]) to study and compare how peripheral glial cells and peritoneal macrophages respond to two types of stimuli.

The first stimulus was the protozoan *Trypanosoma cruzi*, which causes Chagas disease, a significant cause of morbidity and mortality that affects 7.7 million people in Latin America and caused more than 10,000 deaths in 2008 ([@B43]). Resistance to *T. cruzi* infection is associated with the capacity of lymphocytes to generate interferon-γ (IFN-γ), which activates macrophages to produce nitric oxide (NO), the main effector molecule that controls intracellular *T. cruzi* multiplication ([@B23], [@B50]). NO is also related to tissue damage ([@B50], [@B13]), myenteric denervation ([@B6]), neuronal death and reduced neurite density in *T. cruzi* infection ([@B3]).

It has been found that autonomic glial cells are susceptible to infection in human intestines ([@B45]) and their parasitism and responses have been implicated in neuronal death ([@B45], [@B48]). However, it is unclear whether these peripheral glial cells produce inducible NO synthase (iNOS)-derived NO and whether they exert an important role in tissue lesions and neuronal death, as observed in *T. cruzi* infection. It has been suggested that glial-derived NO contributes to the neurodegenerative process observed in the spinal cords of *T. cruzi*-infected interleukin (IL)-12p40 knock-out mice ([@B8]). In addition to the central nervous system (CNS), the enteric nervous system is also compromised in Chagas disease; however, the autonomic glial cell production of NO has not yet been studied.

The second stimulus used in this study was bacterial lipopolysaccharide (LPS), the major component of the outer membrane of Gram-negative bacteria, which induces potent NO production and immune responses ([@B44], [@B36]). Macrophages and resident glial cells in the CNS (astroglia and microglia) express iNOS and produce high levels of NO in response to a wide variety of pro-inflammatory and degenerative stimuli ([@B41]). Although the responses of these cells to these stimuli have been well characterised in vitro, the intracellular mechanisms involved are not completely understood.

Because glial cells have a crucial role in neuronal lesions and survival ([@B29]) and are able to produce NO in response to a variety of stimuli, we aimed to investigate how the response of peripheral glial cells to either *T. cruzi* infection or LPS differed from the response of peritoneal macrophages. Our goal was to establish the importance of peripheral glial cells as a source of NO in Chagas disease while contributing to the study of glial cell biology. Our observations contribute to the understanding of the intestinal form of Chagas disease pathogenesis based on the high susceptibility of autonomic glial cells to *T. cruzi* infection with subsequent NO production, ultimately leading to neuronal lesions.

MATERIALS AND METHODS
=====================

*SCG glial cell culture* - Pure primary cultures of SCG glial cells were prepared as previously described ([@B2]). Briefly, SCGs were removed from one-four-day-old C57BL/6 wild-type (WT) mice after decapitation and enzymatically dissociated in 1× trypsin/ethylenediamine tetraacetic acid solution (Sigma Chemical Company, USA). Isolated sympathetic cells at a final concentration of 10^5^ cells/well were plated in cell culture plates (96 or 24-well; Sarstedt, Germany) coated with a 1:5 dilution of Matrigel (Becton Dickinson, USA) in sterile distilled water and cultured in 10% foetal bovine serum (FBS), 100 UI/mL penicillin (Sigma-Aldrich, USA) and 10,000 µg/mL streptomycin (Sigma-Aldrich) in Dulbecco's Modified Eagle's Medium (DMEM) (Sigma-Aldrich). The cultures were maintained at 37ºC in a humidified 5% CO~2~ incubator for five-eight days before interventions; the culture medium was changed every 48 h.

*Peritoneal macrophage culture* - Macrophages were harvested from the peritoneal cavity of adult WT mice at three days after the injection of 2 mL of 3% (wt/vol) sodium thioglycolate (Sigma Chemical Company), as previously described ([@B44], [@B46]). After centrifugation at 400 *g* for 10 min, the pellet was resuspended in the medium and a single hypotonic lysis was performed as described to remove erythrocytes ([@B21]). Another centrifugation was carried out and the cells were resuspended and plated in cell culture plates (96 or 24-well; Sarstedt), coated with a 1:5 dilution of Matrigel (Becton Dickinson) in sterile distilled water and cultured in 10% FBS, 100 UI/mL penicillin (Sigma-Aldrich) and 10,000 µg/mL streptomycin (Sigma-Aldrich) in DMEM (Sigma-Aldrich). After 2 h, the cultures were washed to remove the non-adherent cells, leaving a 97% pure population of adherent macrophages. The cultures were maintained at 37ºC in a humidified 5% CO~2~ incubator for 24 h before interventions.

*Parasite* - The *T. cruzi* Y strain was used for all experiments. Trypomastigote forms were cultured and purified from the monkey kidney epithelial cell line VERO, as previously described ([@B9]). Parasites were harvested after six days in culture, centrifuged at 150 *g* for 10 min at room temperature (RT), counted in a Neubauer chamber, centrifuged at 450 *g*for 10 min at 4ºC, suspended in 10% FBS supplemented 199 medium and used to infect cultures.

*T. cruzi infection - T. cruzi* trypomastigotes were added to cultures at a parasite-to-cell ratio of 5-10:1. The cells were maintained at 37ºC in a humidified 5% CO~2~ incubator for 48 h in the presence of 200 UI/mL of recombinant murine IFN-γ.

*LPS addition - Escherichia coli* LPS (L-4130; Sigma-Aldrich) was added to the cultures at a final concentration of 50 ng/mL. The cells were maintained at 37ºC in a humidified 5% CO~2~ incubator for 48 h in the presence of 200 UI/mL of recombinant murine IFN-γ.

*Blockade of iNOS activity* - To define the role of NO in *T. cruzi* infection in glial cells in comparison to macrophages, the iNOS inhibitor aminoguanidine (AG) (300 μM, A7009; Sigma-Aldrich) was added to cultures to block iNOS activity.

*Assessment of infection* - Cultures were fixed in 10% neutral buffered formalin solution at 48 h post-intervention (p.i.) and stained with 10% Giemsa (Doles Reagents, Brazil). The infection rate was determined by counting the intracellular amastigote forms, as previously described ([@B50], [@B42]).

*Immunofluorescence* - Cultured fixed cells were washed in phosphate-buffered saline (PBS), permeabilised with 0.25% Triton X-100 (Roche, Switzerland) in PBS containing 2% bovine serum albumin (BSA) (Inlab, Brazil) for 10 min at RT and incubated with 1:40 normal goat serum in PBS containing 0.25% Triton X-100 and 2% BSA for 30 min at RT to block non-specific binding sites. The primary antibodies used to characterise macrophages and glial cells were primary rat anti-mouse F4/80 (1:50; Serotec, UK) and Alexa Fluor 488 goat anti-rat IgG antibodies and primary rabbit anti-glial fibrillary acid protein (GFAP) (1:100; Dako, Denmark) and Alexa Fluor 488 goat anti-rabbit IgG antibodies (1:400; Molecular Probes, USA), respectively. iNOS expression was detected with primary rabbit anti-iNOS (1:100; Chemicon, USA) and Alexa Fluor 546 goat anti-rabbit IgG (1:400; Molecular Probes) antibodies. Secondary antibodies alone were used as specificity controls and uniformly resulted in very low background levels of reactivity. Nuclear staining was assessed using the fluorescent probe Hoechst (0.2 µg/mL; Molecular Probes). The cells were examined by microscopy and digital images were acquired for documentation. The fluorescence intensity was measured by the mean grey value of the binary images from two independent experiments performed in triplicate using ImageJ 1.45s \[National Institutes of Health (NIH), USA\].

*Evaluation of NO* ~*2*~ ^-^ *production* - Culture supernatants collected at 48 h p.i. and stored at -20ºC were assayed for their nitrite concentration by mixing 0.1 mL of culture supernatant with 0.1 mL of 0.1% naphthylethylene diamine dihydrochloride and 1% sulfanilamide plus 2.5% phosphoric acid, as previously described ([@B25]). The absorbance at 540 nm was measured after 10 min and the NO~2~ ^-^ concentration was determined by reference to a standard curve of 1-200 µM NaNO~2~.

*Statistical analysis* - The results were expressed as the mean ± standard error of the mean (parametric data) or as the median (non-parametric data) of at least three independent experiments. Data were analysed for statistical significance using a non-paired *t* test (parametric data) or a Mann-Whitney *U* test (non-parametric data). Probability values (p) of 0.05 or less were considered significant. All analyses were carried out using GraphPad InStat software (USA).

*Ethics*- All animals used in the research were acquired and cared for in accordance with the NIH Guide for the Care and Use of Laboratory Animals guidelines and the principles presented in the Guidelines for the Use of Animals in Neuroscience Research. All animal protocols were approved by the university Ethical Committee in Animal Experimentation.

RESULTS
=======

The glial cells in all cultures showed a flat and irregular shape, from spindle-like to polygonal and few cytoplasmic processes. Most glial cells were immunopositive for the glial cell marker GFAP ([Fig. 1A](#f01){ref-type="fig"}). The macrophages in culture showed irregular shapes, from round to fusiform, and were immunopositive for the macrophage marker F4/80 ([Fig. 1B](#f01){ref-type="fig"}). Comparatively, the glial cell cytoplasm was larger than the macrophage cytoplasm ([Fig. 1A](#f01){ref-type="fig"}, [B](#f01){ref-type="fig"}).

Fig. 1: *Trypanosoma cruzi*-infected glial cell or macrophage cultures. A, B: glial fibrillary acid protein immunopositive glial cells (A) and F4/80-immunopositive macrophages (B) in culture. Nuclear staining was assessed using the fluorescent probe Hoechst; C, D: *T. cruzi*-infected glial cells (C) or macrophages (D), showing intracellular amastigotes (arrows) 48 h post-intervention (p.i.). Giemsa staining; E, F: inducible nitric oxide synthase immunopositivity in *T. cruzi*-infected glial cells (E) or macrophages (F and insert) 48 h p.i. Nuclear staining was assessed using the fluorescent probe Hoechst.

After 48 h of *T. cruzi* infection, most glial cells showed intense parasitism and swollen cytoplasm, with numerous intracellular amastigotes ([Fig. 1C](#f01){ref-type="fig"}). Some macrophages were parasitised and a few intracellular amastigotes could be observed in the cytoplasm ([Fig. 1D](#f01){ref-type="fig"}).

To determine the infection rate, parasitised cells in both cultures were counted. A quantitative analysis showed a higher number of infected cells in the glial cell cultures than in the macrophage cultures ([Fig. 2A](#f02){ref-type="fig"}). However, when iNOS activity was blocked by AG, there was a significant decrease in the number of infected glial cells, with a significant increase in infected macrophages ([Fig. 2A](#f02){ref-type="fig"}).

Fig. 2: *Trypanosoma cruzi* infection and inducible nitric oxide synthase (iNOS) expression in glial cells and macrophages. A: percentage of *T. cruzi*-infected cells in glial cell or macrophage cultures. The data correspond to the mean of five independent experiments ± standard error of the mean (SEM). Asterisks mean statistically significant difference (p \< 0.01, unpaired *t* test); B: number of amastigotes/cell in *T. cruzi*-infected glial cell or macrophage cultures. The data correspond to the mean of five independent experiments ± SEM (p \< 0.05, unpaired *t* test); C: intensity of iNOS immunofluorescence in *T. cruzi*-infected glial cell or macrophage cultures 48 h post-intervention. The data correspond to the mean of two independent experiments in triplicate ± SEM (p \< 0.05, unpaired *t* test); A: aminoguainidine; G: glial cell; I: interferon-γ; M: macrophage; T: *T. cruzi*.

To calculate the degree of cell parasitism per infected cell in both cultures, the number of intracellular amastigotes was counted per infected cell of 100 cells ([Fig. 2B](#f02){ref-type="fig"}). No statistically significant difference was observed when both cell types were compared in the presence of NO. However, cell parasitism decreased in both cell types when iNOS was blocked by AG ([Fig. 2B](#f02){ref-type="fig"}).

The glial cells expressed iNOS and were highly infected with intracellular amastigotes ([Fig. 1E](#f01){ref-type="fig"}). As expected, the *T. cruzi*-infected macrophages also showed iNOS immunopositivity ([Fig. 1F](#f01){ref-type="fig"}). When both cultures were compared, iNOS cytoplasmic fluorescence was systematically more intense in the macrophages than in the glial cells ([Fig. 1E](#f01){ref-type="fig"}, [F](#f01){ref-type="fig"}). A quantitative analysis of the fluorescence intensity showed that the macrophages expressed higher iNOS immunopositivity than the glial cells ([Fig. 2C](#f02){ref-type="fig"}).

In comparison to the controls, the *T. cruzi*-infected and IFN-γ-activated glial cells showed significantly higher levels of NO production at 48 h p.i. ([Fig. 3A](#f03){ref-type="fig"}). Similarly, treatment with IFN-γ and *T. cruzi* infection resulted in significant levels of NO production in comparison to all controls in macrophage cultures. Nonetheless, the macrophages were more responsive to LPS than to *T. cruzi* in the presence of IFN-γ ([Fig. 3A](#f03){ref-type="fig"}, [B](#f03){ref-type="fig"}). There was no significant difference with regard to NO production between the *T. cruzi*-infected and IFN-γ-activated glial cell or macrophage cultures.

Fig. 3: nitric oxide (NO) production in glial cells and macrophages. *Trypanosoma cruzi*-infected (A) or lipopolysaccharide-activated glial cell or macrophage cultures (B). The data correspond to the median of four (A) or three (B) independent experiments in triplicate. Asterisks mean statistically significant differences to controls (medium) (p \< 0.01, Mann-Whitney *U*test). MLI statistically different from MTI (p \< 0.01, unpaired *t* test). G: glial cell; I: interferon-γ; L: lipopolysaccharide;M: macrophage; T: *T. cruzi*.

LPS addition resulted in significantly higher levels of NO production in both the glial cell and macrophage cultures in comparison to the control, LPS or IFN-γ alone at 48 h p.i. ([Fig. 3B](#f03){ref-type="fig"}). However, the macrophages produced greater amounts of NO when compared to the glial cell cultures when both LPS and IFN-γ were present. When the *T. cruzi*-infected and IFN-γ-activated glial cell cultures were compared to the LPS and IFN-γ-activated glial cell cultures, there was no difference regarding NO production, regardless of the stimulus ([Fig. 3](#f03){ref-type="fig"}) and the levels of NO production were very similar.

DISCUSSION
==========

We used a model of primary glial cell culture from the SCG to investigate glial cell activation and iNOS-derived NO production after *T. cruzi* infection or LPS addition and compared this to peritoneal macrophage cultures under the same conditions. Here, we show that *T. cruzi* infection was greater in glial cells than in macrophages, despite similar levels of NO production. Glial cells responded similarly to both stimuli, whereas macrophages responded better to LPS than to *T. cruzi* infection.

Despite the close association of glial cells to neurons in the peripheral ganglia and CNS and their participation in pro and anti-inflammatory responses ([@B29], [@B41]), the cellular activation pathways are not well defined for this cell type ([@B41], [@B27]). Our group has studied SCG neurons ([@B3]) and glial cells ([@B2]) due to their participation in the neuronal degenerative changes induced by *T. cruzi*. This parasite has a tropism to nervous tissues in intracardiac ganglia ([@B33]) and the intramural myenteric plexus, a site where glia parasitism has been reported, whereas neuronal infection is rarely observed ([@B45], [@B6]). Autonomic ganglia, such as intracardiac and celiac ganglia and the enteric nervous system are preferentially affected in human and experimental Chagas disease and most likely play an important role in the disease's physiopathology ([@B45], [@B33], [@B6]). The SCG is a prototype of autonomic ganglia and SCG primary neuronal cultures are widely considered a classical instrument of investigation ([@B7]). However, SCG glial cells have been less explored than neurons and have never been used for the in vitro study of *T. cruzi* infection.

Our results indicated that in vitro glial cells are susceptible to *T. cruzi* infection, as previously described in vivo ([@B45], [@B6]). Astrocytes are very susceptible to *T. cruzi* multiplication in vitro ([@B49]) and here we show that sympathetic glial cells are susceptible as well, which has implications for neuronal lesions in autonomic and enteric ganglia. Moreover, *T. cruzi* infection in glial cells was 1.6 times greater than in macrophages at a similar parasite to cell ratio. Despite being infected more easily, glial cells showed no morphological signs of cell degeneration or death. *T. cruzi* promotes glial cell survival through the neurotrophin-3 receptor TrkC ([@B52], [@B53]) and it has been shown that macrophages are infected less frequently than are other cell types ([@B47]), as also observed in our study. It is reasonable to suggest that glial cells have a more permissive behaviour toward *T. cruzi* infection because they have a larger cytoplasm and are non-professional phagocytes ([@B38]). Furthermore, it has been described that glial cells may favour parasite survival and multiplication ([@B49]). Macrophages, in contrast, are innate immune cells and naturally resistant to intracellular infections ([@B47]) and may express distinct genes that limit intracellular parasite multiplication ([@B18]). *T. cruzi* invades several cell types by exploiting phagocytic or non-phagocytic mechanisms, depending on the cell involved ([@B12]). Thus, the entry mechanism of *T. cruzi* into peripheral glial cells deserves further investigation, as has been performed for other cells ([@B10], [@B4], [@B53]).

One might predict that the greater infection rate in glial cells would be associated with impaired resistance and deficient NO production. Instead, the supernatant NO levels of *T. cruzi*-infected glial cells were similar to macrophage levels under the same conditions. However, considering that glial cells showed a higher rate of infection and produced similar levels of NO, their response appears to be less intense than that observed for macrophages. When assessing iNOS intensity by immunofluorescence, a lower quantity of expressed protein is observed. The differential regulation mechanisms of the iNOS gene in macrophages and glial cells ([@B23], [@B50], [@B37], [@B41]) could explain the greater infection rate and similar NO production in glial cell cultures, in agreement with the paradoxical protective role of glial cells.

It has been shown that the parasite *Toxoplasma gondii* exerts an inhibitory effect on iNOS expression in microglia ([@B40]), which may also be the case for *T. cruzi* and SCG glial cells. Moreover, the host defence activity of human microglia against *T. gondii* does not depend on NO, but primarily on IFN-γ, tumour necrosis factor-α and IL-6 ([@B14]). The synthesis and secretion of such mediators, as well as leukotriene B4 ([@B42], [@B46]), could justify distinct infection rates in glial cells and macrophages. It is also known that *T. cruzi* trans-sialidase protects Schwann cells from cell death by activating the phosphatidylinositol 3-kinase/Akt pathway ([@B16]). Hence, it is possible that our glial cells are more resistant to *T. cruzi* infection, showing a greater infection rate without morphological evidence of cell death and with less trypanocide activity through NO in comparison to macrophages. However, due to the proximity of glial cells to ganglionic neurons, their products of activation may have damaging effects that may be particularly harmful in both the cardiac and intestinal forms of Chagas disease, as NO has been associated with neuronal death in *T. cruzi* infection ([@B3]).

Distinct roles for NO in glial cells or macrophages in the control of *T. cruzi* infection might be suggested by the decreased number of infected glial cells when iNOS activity was blocked by AG. Although it has been shown that the absence of NO leads to higher parasitism ([@B6]), some in vitro studies have demonstrated that the addition of AG decreased cell parasitism, as observed in our study. Other mechanisms known to control parasite replication may also be triggered and the partial inhibition of parasitism was due to cytokine production ([@B1], [@B34]). Moreover, both in vivo and in vitro studies have shown that NO is not required for the control of *T. cruzi* infection and the enhanced expression of other inflammatory mediators may in part compensate for the lack of iNOS ([@B19], [@B35]). We believe that our glial cells may compensate for iNOS blockade by releasing cytokines and chemokines that control *T. cruzi* infection to a greater degree than macrophages. We could also assume that NO might be less effective in glial cells as a mechanism of parasite control. In contrast, the blockade of NO production reduced cell parasitism in both cell types and this may be due to distinct mechanisms of parasite uptake and replication, as previously shown ([@B1]).

The addition of LPS induced greater levels of nitrites in macrophage cultures compared to glial cell cultures. Indeed, it is known that *T. cruzi* and LPS have diverse effects in macrophages by activating different Toll-like receptors (TLRs) ([@B39]), whereas glial cell activation pathways have not been well established ([@B41]). It has been shown that iNOS activation is different in astrocytes and macrophages ([@B37]), which led us to believe that peripheral glial cells may also exhibit different levels of iNOS activation. Although macrophages showed greater NO production in LPS-primed cultures in comparison to *T. cruzi-*infected cultures, glial cells showed similar nitrite levels under either stimulus. Our results indicate that autonomic glial cells respond similarly to LPS and *T. cruzi*, which are known to activate TLR4 and TLR2, respectively, in macrophages ([@B30], [@B39]). Although the transduction signals generated by distinct TLRs are very similar, cellular responses may be quite different ([@B11]). Central glial cells respond to LPS *via* the activation of TLR4 ([@B32]), as in macrophages ([@B30]); in the presence of LPS, Schwann cells express TLR4 ([@B15]) and enteric glial cells produce NO ([@B17]). However, detailed information regarding TRL4 activation following iNOS induction in the presence of LPS in peripheral glial cells has not been described. Thus, it is reasonable to suggest that iNOS activation by *T. cruzi* and LPS in SCG glial cells involves different TLRs. Although is not known whether SCG glial cells express TLR4 or TLR2, this appears likely because they are the best characterised TLRs with regard to the recognition of microbial motifs and LPS, respectively ([@B28]). Further studies of TLR expression in SCG glial cells are intended.

Our observations contribute to the understanding of Chagas disease pathogenesis, as based on the high susceptibility of autonomic glial cells to *T. cruzi* infection with subsequent NO production. Moreover, our findings will facilitate future research into the immune responses and activation mechanisms of peripheral glial cells, which are important for understanding the paradoxical responses of this cell type in neuronal lesions and neuroprotection.
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